5-HT3 receptor antagonism and psychoactivity

被引:0
|
作者
Sullivan, JT
Preston, KL
Testa, MP
Bell, J
Jasinski, DR
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205
[2] JOHNS HOPKINS BAYVIEW MED CTR,BALTIMORE,MD
关键词
ondansetron; cocaine; psychoactivity; subjective effects; 5-HT3; antagonism; COCAINE; MORPHINE;
D O I
10.1177/026988119601000302
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The purpose of this study was to assess the acute psychoactive and physiological properties of 5-HT3 antagonism using ondansetron as a probe. Ondansetron is used clinically as an anti-emetic but is also under treatment consideration for a range of psychiatric disorders including drug abuse. A 15 min infusion of 40 mg ondansetron, a 1 min infusion of 25 mg of cocaine (positive control) and their respective placebos were tested intravenously in eight volunteers with histories of drug abuse in a blinded cross-over study. Ondansetron responses could not be distinguished from the placebo. Cocaine produced typical subjective and physiological effects. These findings indicate that the prototypic 5-HT3 receptor antagonist ondansetron does not produce acute psychoactive effects when infused at doses of up to 40 mg and has no rewarding effects with this regime.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 50 条
  • [31] 5-HT3 receptor antagonist for the treatment of tendinopathy
    Mousavizadeh, Kazem
    Stratz, Thomas
    Mueller, Wolfgang
    Fiebich, Bernd L.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (07): : E4 - E4
  • [32] Recent developments in 5-HT3 receptor pharmacology
    Thompson, Andrew J.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2013, 34 (02) : 100 - 109
  • [33] MOLECULAR MODELING OF 5-HT3 RECEPTOR LIGANDS
    EVANS, SM
    GALDES, A
    GALL, M
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 40 (04) : 1033 - 1040
  • [34] Conformational transitions of the serotonin 5-HT3 receptor
    Lucie Polovinkin
    Ghérici Hassaine
    Jonathan Perot
    Emmanuelle Neumann
    Anders A. Jensen
    Solène N. Lefebvre
    Pierre-Jean Corringer
    Jacques Neyton
    Christophe Chipot
    Francois Dehez
    Guy Schoehn
    Hugues Nury
    Nature, 2018, 563 : 275 - 279
  • [35] The Central 5-HT3 Receptor in CNS Disorders
    Floyd E. Bloom
    Marisela Morales
    Neurochemical Research, 1998, 23 : 653 - 659
  • [36] Analgesic activity of 5-HT3 receptor antagonists
    Spasov, AA
    Chernikov, MV
    Kiabiya, ST
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2005, 139 (04) : 424 - 426
  • [37] 5-HT3 receptor antagonist for the treatment of tendinopathy
    Kazem Mousavizadeh
    Thomas Stratz
    Wolfgang Mueller
    Bernd L Fiebich
    Nature Clinical Practice Rheumatology, 2008, 4 : E4 - E4
  • [38] THE SELECTIVITY OF THE CHANNEL COUPLED TO THE 5-HT3 RECEPTOR
    YAKEL, JL
    SHAO, XM
    JACKSON, MB
    BRAIN RESEARCH, 1990, 533 (01) : 46 - 52
  • [39] A Gating Mechanism of the Serotonin 5-HT3 Receptor
    Yuan, Shuguang
    Filipek, Slawomir
    Vogel, Horst
    STRUCTURE, 2016, 24 (05) : 816 - 825
  • [40] Conformational transitions of the serotonin 5-HT3 receptor
    Polovinkin, Lucie
    Hassaine, Gherici
    Perot, Jonathan
    Neumann, Emmanuelle
    Jensen, Anders A.
    Lefebvre, Solene N.
    Corringer, Pierre-Jean
    Neyton, Jacques
    Chipot, Christophe
    Dehez, Francois
    Schoehn, Guy
    Nury, Hugues
    NATURE, 2018, 563 (7730) : 275 - +